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ABSTRACT
Pds5 is required for sister chromatid cohesion, and
somewhat paradoxically, to remove cohesin from
chromosomes. We found that Pds5 plays a critical
role during DNA replication that is distinct from its
previously known functions. Loss of Pds5 hinders
replication fork progression in unperturbed human
and mouse cells. Inhibition of MRE11 nuclease activ-
ity restores fork progression, suggesting that Pds5
protects forks from MRE11-activity. Loss of Pds5 also
leads to double-strand breaks, which are again re-
duced by MRE11 inhibition. The replication function
of Pds5 is independent of its previously reported in-
teraction with BRCA2. Unlike Pds5, BRCA2 protects
forks from nucleolytic degradation only in the pres-
ence of genotoxic stress. Moreover, our iPOND anal-
ysis shows that the loading of Pds5 and other co-
hesion factors on replication forks is not affected
by the BRCA2 status. Pds5 role in DNA replication is
shared by the other cohesin-removal factor Wapl, but
not by the cohesin complex component Rad21. Inter-
estingly, depletion of Rad21 in a Pds5-deficient back-
ground rescues the phenotype observed upon Pds5
depletion alone. These findings support a model
where loss of either component of the cohesin re-
leasin complex perturbs cohesin dynamics on repli-
cation forks, hindering fork progression and promot-
ing MRE11-dependent fork slowing.
INTRODUCTION
Accurate DNA replication is essential to protect genome
integrity and for the high-fidelity transmission of genomic
information to daughter cells. Agents that arise from ei-
ther normal metabolism or exposure to natural or artifi-
cial products in the environment constantly challenge pro-
gressing DNA replication forks. In addition to DNA le-
sions, increasing evidence suggests that intrinsic replication
fork obstacles such as transcribing RNA polymerases, un-
usual DNA structures, tightly-bound protein–DNA com-
plexes and oncogene activation may also perturb fork pro-
gression (1,2).
The ring-shaped cohesin complex tethers sister chro-
matids together during DNA replication and consists of
two structural maintenance of chromosome (SMC) pro-
teins, Smc1 and Smc3, and two non-SMCcomponents, Scc1
(also referred as Rad21, Mcd1 or Kleisen) and Scc3 (also
referred as SA or STAG) (3–5). Whereas a single Scc3 is
present in yeast, two SA proteins, SA1 and SA2, are found
in higher eukaryotes that form two distinct cohesin com-
plexes in somatic cells: cohesin-SA1 and cohesin-SA2 (6,7).
The cohesin ring complex is loaded onto chromosomes by
the Nipped-B/NIPBL kollerin complex (Scc2 or delangin)
and its partner MAU-2 (Scc4), and is removed by the re-
leasin complex consisting of the Pds5 and Wapl proteins
(8,9). The main function of cohesin is to hold newly repli-
cated chromatids together in order to mediate sister chro-
matid cohesion and ensure accurate chromosome segrega-
tion during mitosis (10–12). However, increasing evidence
suggests that cohesin plays crucial roles in multiple cellular
processes including chromosome condensation, gene regu-
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lation and DNA damage repair (11,13). The fact that cohe-
sion is established during S-phase, when new sister DNAs
are synthesized by the replication complex, points to an in-
timate relationship between DNA replication and cohesion
establishment. Indeed, cohesin has been shown to interact
with several replication factors including PCNA and the
alternative clamp loader formed by the Ctf18-Replication
Factor C complex, as well as the CtF4 homotrimers. All
these interactions contribute to proper cohesion establish-
ment (14–20). However, our current knowledge of how the
replication machinery regulates cohesin and vice versa is
limited.
The Precocious Dissociation of Sister protein Pds5 was
initially discovered as an essential factor for holding sis-
ter chromatids together during mitosis in Saccharomyces
cerevisiae (21,22). The role of Pds5 in cohesion has been
highly debated because Pds5 is required for sister chro-
matid cohesion, and somewhat paradoxically, also to re-
move cohesin from chromosomes (23,24). Recent studies
suggest that Pds5 acts as a scaffold protein to recruit dif-
ferent factors to the cohesin ring (25–27). Depending on
its binding partner, Pds5 may stabilize the cohesin ring on
DNA or promote its unloading. As previously mentioned,
Pds5 associates with Wapl and together they unload co-
hesin. Soronin competes withWapl for binding to Pds5 (28).
De-phosphorylation of Sororin by the Shugoshin and Pro-
tein Phosphatase 2A (SGO1-PP2A) complex strengthens
Sororin binding to Pds5, stabilizing the cohesin complex at
centromeres until metaphase (29). On the other hand, the
mitotic factors Aurora B and CdK1 phosphorylate Soronin
destabilizing its interaction with Pds5 and allowing Pds5
to re-associate with Wapl, leading to cohesin removal from
chromosome arms (29,30).
Two Pds5 variants are expressed in mammalian cells,
Pds5A and Pds5B (also known as APRIN). Both variants
are required for cohesion establishment by facilitating Smc3
acetylation and recruiting Soronin and Wapl to the com-
plex (26,31). However, Pds5B appears to be specifically im-
portant to ensure centromeric cohesion (31). Interestingly,
recent reports point to a previously unappreciated function
of Pds5 in DNA damage repair and homologous recombi-
nation (HR) (32–34). These studies have been sparked by
the discovery that Pds5B interacts with the breast cancer
susceptibility protein BRCA2, a protein well-known for its
roles inHRand replication fork stability (35,36). Pds5B loss
perturbs HR and sensitizes cells to DNA damaging agents
(32), and recent mechanistic studies suggest that Pds5B
stimulates Rad51-mediated strand invasion through its in-
teraction with BRCA2 (33). A role of Pds5B in replication
and DNA damage repair is also supported by observations
that downregulation of Pds5B sensitizes breast cancer cells
to DNA-damaging chemotherapy and that low Pds5B ex-
pression correlates with better breast and ovarian patient
survival (32). While the cohesin regulatory and HR func-
tion of Pds5 have been relatively well-characterized, its role
in DNA replication is poorly defined. Moreover, the con-
tribution of the Pds5A variant to the replication and repair
function of Pds5 remains unclear.
Here, we set out to investigate the function of the two
isoforms of Pdsd5 in DNA replication. Our findings reveal
that both Pds5 isoforms play an important role during repli-
cation fork progression in unperturbed cells. Loss of Pds5
leads toMRE11-dependent fork slowing andDSB accumu-
lation. This function is uncoupled from the interaction with
BRCA2 and seems to be related to the cohesin releasin ac-
tivity of the Pds5 and Wapl proteins, suggesting that co-
hesin accumulation on replication forks may represent a
new important obstacle to replication fork progression and
genome duplication.
MATERIALS AND METHODS
Cell lines, cell culture, and gene silencing
Human Osteosarcoma (U-2 OS) cells (ATCC® HTB-
96™) and hTERT Retinal Pigment Epithelial-1 (RPE) cells
(ATCC® CRL-4000™) were transfected by siRNA tech-
nology to deplete Pds5B (Dharmacon ON-TARGETplus
Human Pds5B siRNA Cat. No. L-010362-00-005, 50 nM
for 72 h) (32); Pds5A (Dharmacon sequence: 5′-TTC
TTCCTCAGGAACCC-CATT-3′, 50 nM for 48 h) (37);
Wapl (Dharmacon sequence: 5′-CGGACTACCCTTAGC
ACAA-3′, 50 nM for 48 h) (37); Rad21 (Dharmacon se-
quence: 5′-AUAC-CUUCUUGCAG-ACUGU-3′, 50 nM
for 48 h) (38); BRCA2 (Dharmacon ON-TARGETplus
BRCA2, Cat. No. L-003462-00, 25 nM for 48 h) (39,40);
MRE11 A (Dharmacon ON-TARGETplus, Cat. No. L-
009271-00, 50 nM for 48 h) (41); Nbs1 (Dharmacon
sequence: 5′-CCAACUAAAUUGCCAAGUAUU-3′, 50
nM for 48 h) (42) and Rad50 (Dharmacon sequence: 5′-C
TGCGACTTGCTCCAGATAAA-3′, 50 nM for 48 h) (43),
Rad51 (Ambion, Cat. No. 4390827, sequence- 5′-GUGCU
GCAGCCUAAUGATT-3′, 50 nM, 48 h) (40), Smarcal1
(Dharmacon, Cat. No. D-013058-04-002, sequence- 5′-GA
AUCUCACUUCCUCAAAA-3′, 20 nM, 72 h) (44). Si-
lencer select negative control siRNA (Ambion, Cat. No.
4390843, 50 nM for 48 h) and Luciferase Duplex (Dharma-
con, Cat. No. P-002099-01-20, 50 nM for 48 h) were used
for the control experiments. RNAi transfection was carried
out using RNAiMAX (ThermoFisher Scientific Cat. No.
13778030) following the manufacturer’s instructions. U-2
OS and RPE cells were cultured in Dulbecco’s modified Ea-
gle’s medium (DMEM Sigma, Poole, UK) supplemented
with 10% Fetal Bovine Serum (FBS) and 100 U/ml peni-
cillin and 100 g/ml streptomycin (1%) at 37◦C, 5% CO2.
One clone each of Pds5A knock-out (KO), Pds5B
KO and Wild Type (WT) Mouse Embryonic Fibroblasts
(MEFs) (31) that had been immortalized using SV40 large
T antigen (iMEFs) were kindly provided byDr Ana Losada
(CINOMadrid Spain). iMEFs were cultured in Dulbecco’s
modified Eagle’s medium (DMEM Sigma, Poole, UK) sup-
plemented with 20% Fetal Bovine Serum (FBS) and 1%
penicillin–streptomycin at 37◦C, 5% CO2.
pRetroX Tet-ON Advanced HEK293T cells (Takara Bio
Inc.) that stably express the doxycycline-regulated transac-
tivator protein were transiently transfected with pRetroX-
Tight.puromyc-BirA*Pds5B (APRIN) with Lipofectamine
2000 (Invitrogen; (45)). Cells were incubated with 0.5g/ml
puromycin 48 h after transfection. Upon colony forma-
tion, single clones were isolated and screened for myc-BirA-
Pds5B protein after doxycycline induction (1 g/ml doxy-
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Antibodies for IP and western blot analysis
Levels of intracellular Pds5B, Pds5A, BRCA2, Rad21,
Wapl, MRE11, Nbs1, Rad50, Rad51, Smarcal1, Chk-
1, pChk1, H2AX, pRPA 32 (S33),  -H2AX, PCNA,
GAPDH, Histone H3 and Tubulin were determined by
western blot analysis of cell extracts. Anti-Pds5B (APRIN,
Novus, Cat. No.100-755; 1:1000); anti-Pds5A (Novus,
Cat. No. A300-088A; 1:1000), anti-Wapl A-7 (Santa Cruz
Biotechnology, Cat. No. sc-36518; 1:500), anti-BRCA2
(Calbiochem, Cat. No. OP-95; 1:1000), anti-Rad21 (Bethyl,
Cat. No. A300-080A; 1:1000), anti- MRE11-A rabbit poly-
clonal (Sigma-Aldrich, Cat. No. M6193: 1:1000); anti-
p95 Nbs1 (Abcam, Cat. No. ab32074; 1:1000) anti-Rad50
(Abcam, Cat. No. ab181602; 1:100); anti-PCNA (F-2)
(Santa Cruz, Cat. No, sc-25280; 1:500); anti-Histone
H3 (Abcam, Cat. No. ab1791; 1:30 000); anti-GAPDH
(EPR16891) (Abcam, Cat. No. ab181602; 1:75 000); anti-
rabbit (Thermo Fisher Scientific, Cat. No. 31460; 1:10 000);
anti-mouse (Sigma-Aldrich, Cat. No. A3562; 1:10 000);
anti-tubulin mouse monoclonal, (Sigma-Aldrich, Cat. No.
T5168; 1:5000); anti-RAD51 rabbit polyclonal (Sigma-
Aldrich, Cat. No. 05-0530-I; 1:1000); anti-Smarcal1 mouse
monoclonal (Santa Cruz Biotechnology, Cat. No. E-12;
1:500); anti-Chk1 mouse monoclonal (Santa Cruz Biotech-
nology, Cat. No. sc-8408; 1:1000); anti-pChk1 (S345) rab-
bit monoclonal (Cell Signaling Technology, Cat. No. 2348;
1:1000); anti-phospho-H2AX mouse monoclonal (Abcam,
Cat. No. ab26350; 1:1000); anti-CENPF rabbit polyclonal
(Abcam, Cat. No. ab5; 1:300); anti-53BP1 mouse mon-
oclonal (BD Biosciences Cat. No. 612522; 1:1000); anti-
phospho RPA 32 (S33) rabbit polyclonal (Bethyl, Cat. No.
A300-246A, 1:1000); Hoechst 33342 (Sigma-Aldrich. Cat.
No. B2261).
DNA fiber analysis
Asynchronously growing cells were labeled with two
thymidine analogues: 20 M 5-iodo-2′-deoxyuridine
(IdU; Sigma-Aldrich) followed by 200 M 5-chloro-2′-
deoxyuridine (CldU; Sigma-Aldrich) for the indicated
times. For the fork restart experiments, cells were washed
twice with PBS after the first pulse and treated with 4 mM
HU for 5 h before adding the second thymidine analog.
To inhibit MRE11 activity, cells were treated with MRE11
inhibitor Mirin (Sigma Aldrich Cat. No. M9948). Cells
were then harvested, lysed and the DNA was spread on a
positive coated slide as described (46). Briefly, cells were
harvested and resuspended in PBS at 100 000 cells/ml. 2
l of this cell solution was mixed with 8 l of lysis buffer
(200 mM Tris–HCl pH 7.5; 50 mM EDTA; 0.5% SDS)
on a glass slide. After 5 min, the slides were tilted at a
20–45◦ angle, and the resulting DNA spreads were air
dried, fixed in 3:1 methanol/acetic acid and stored at 4◦C.
The DNA fibers were denatured with 2.5 M HCl for 1
h, washed with PBS, and blocked with 5% BSA in PBS
for 1 h. DNA immunostaining was performed with rat
anti-BrdU antibody (1:50; AbCys SA, Cat. No. ABC117
7513) for CldU and mouse anti-BrdU antibody (1:50;
Becton Dickson, Cat. No. 347580) for IdU in a humid
chamber at room temperature for 1 h. The following
secondary antibodies were used: anti-rat Alexa 488 (1:100;
Molecular Probes, Cat. No. A21470) and anti-mouse Alexa
546 (1:100; Molecular Probes, Cat. No. A21123) at room
temperature for 45 min. The slides were air dried and
mounted with Prolong Gold Antifade reagent (Invitrogen).
Images were sequentially acquired (for double-label) with
LAS AF software using TCS SP5 confocal microscope
(Leica). A 63×/1.4 oil immersion objective was used. The
DNA tract lengths were measured using ImageJ and the
values were converted into micrometers using the scale
bars created by the microscope. Statistical analysis was
done using GraphPad Prism Software, (San Diego, CA,
USA). Statistical significance was assessed using unpaired
non-parametric Mann–Whitney compared ranks t-test.
More than 300 fibers were measured for each data set. The
statistics for all these experiments measuring changes in the
size of the IdU or CldU tracts were calculated on the total
number of DNA tracts measured in each given sample
(usually n ≥ 300). For the fork restart experiments, the
percentage of stalled forks was calculated on the basis of at
least 1000 tracts counted in each independent experiment.
All DNA fiber experiments were performed in duplicate
or triplicate, as indicated in the figure legends. Additional
information on the minimal number of tracts that should
be measured for a reliable estimation of changes in fork
speed within a given sample can be found in (47,48).
Affinity capture of biotinylated proteins
Cells were incubated for 24 h in complete media supple-
mented with 1 g/ml doxycycline. Five hours before the
end of the incubation period, biotin 50 M was added to
the media, with or without 4 mM hydroxyurea (HU). Non-
induced cells (–DOX) were treated with 50 uM biotin. After
three cold PBS washes, cells were lysed for 30 min at 4◦C in
a 1:4 ratio (g of cells:ml of buffer) using RIPA buffer (50
mM Tris–HCl pH 7.5, 150 mM NaCl, 1% NP-40, 1 mM
EDTA, 1 mM EGTA, 0.1% SDS) supplemented with 250
U of benzonase, 0.5% sodium deoxycholate and 1× com-
plete protease inhibitor (Roche). Lysates were then soni-
cated as followed: 3 × 10 s at 30% amplitude on ice and
centrifuged at 16 000g for 30 min. Equal volumes of su-
pernatants were incubated with 35 l of sepharose beads
(Streptavidin-Sepharose High Performance; GE Health-
care) for 3 h at 4◦C under rotation. Beads were collected
and washed five times in RIPA buffer. Bound proteins were
elutedwith 35l of Laemmli SDS-sample buffer and heated
at 95◦C for 10 min. Sample were loaded on NuPAGE™
3–8% Tris-Acetate protein gels (Invitrogen) in Tris-Acetate
running buffer according to the manufacturer’s instructions
and transferred on Nitrocellulose membrane (Amersham)
using XCell II Blot Module (Invitrogen) in 20% methanol
transfer buffer. Immunoblot were performed using anti-
BRCA2-OP95 (1:250, Millipore), anti-Pds5 (1:5000, Bethyl
Laboratories A300-538A), anti-GFP (1:1000, Roche).
GFP-trap pull-down
HEK293T were plated to 80% confluency and trans-
fected with peGFP-C1, or peGFPC1-Pds5B vector using
TransIT®-293 Transfection Reagent (Mirus Bio LLC) ac-
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after transfection, cells were treated with 4 mM HU for 5
h, washed twice with cold PBS, and lysed in lysis buffer (50
mM Tris–Cl, pH 7.5, 150 mM NaCl, 0.5% NP40, PMSF,
aprotinin, leupeptin, NaF, Na2VO4) supplemented with
Benzonase (25 U) and 2.5 mM MgCl2 for 30 min at 4◦C.
Lysates were sonicated (3 × 10 s at 30% amplitude on ice)
and centrifuged at 16 000g, 30 min, 4◦C. Proteins were in-
cubated with GFP-beads for 1 h at 4◦C. Beads were washed
four times with lysis buffer and bound proteins were eluted
in 50 l of Laemmli SDS-sample buffer and heated at 95◦C
for 10 min. Proteins were detected using the same approach
described for the affinity capture of biotinylated proteins.
Chromatin fractionation
Chromatin fractionation experiments were performed fol-
lowing a previously described procedure (49). Briefly, pro-
teins bound to chromatin were isolated using a two-step
fractionation procedure, in which cytosolic proteins were
extracted using a buffer containing 10 mMHEPES, pH 7.9,
10 mM KCl, 1.5 mM MgCl2, 0.34 M sucrose, 10% glyc-
erol, 1 mMDTT 0.1% Triton X-100 and protease inhibitor
cocktail. The pellet was then further fractionated releasing
chromatin bound proteins using a buffer containing 3 mM
EDTA, 0.2 mM EGTA, 1 mMDTT and protease inhibitor
cocktail. Cytosolic fraction and chromatin bound proteins
were run on a western blot to assess the levels of proteins
bound to chromatin.
Neutral comet assay for DSB detection
Neutral comet assay was performed as previously described
(40). Briefly, 700 cells were resuspended in 70 l 0.5% low
melting point agarose (Trevigen, Cat. No. 4250-050-02) and
spread on a comet slide (Trevigen, Cat. No. 4250-200-03).
Cells were lysed in a cold lysis solution (Trevigen, Cat. No.
4250-050-01) at 4◦C for 30 min. DNA migration was per-
formed in TBE buffer at 1 V/cm for 30 min. Slides were
washed in milliQ water, fixed with ethanol 70% for 30 min
and dried at room temperature. Comets were labeled with
SYBR® Gold Nucleic Acid Gel Stain (ThermoFisher) for
30 min. Images were acquired with a fluorescence micro-
scope (LEICA DMU 4000B; 20×/0.4 CORR) coupled to
the LEICADFC345FX camera. The images were analyzed
using the OpenComet plug-in from ImageJ. At least 100
comets were scored per sample in each experiment. Olive
moment measures DSBs as a product of the amount of
DNA present (intensity) times the size of the broken DNA
pieces (length) in the tail.
Chromosome spreads
Cells were treated with 10 M nocodazole for 4 h. Cells
were collected, washed and resuspended in 10ml of warmed
hypotonic solution (10 mM KCl, 10% FBS) for 10 min at
37◦C. Cells were fixed by adding 500 l of cold fixation
buffer (acetic acid:ethanol 1:3). Cell pellets were washed
four times with the cold fixation buffer and stored in this
buffer at 4◦C overnight. The nuclei were spread on cold
slides. The slides were air dried overnight and mounted
with Prolong Gold Antifade (Invitrogen) with DAPI. Im-
ages were acquired with a fluorescence microscope (LEICA
DMU 4000B; 63×/1.40–0.60 NA oil) coupled to the LE-
ICA DFC345FX camera. The images were analyzed with
ImageJ. At least 50 metaphases per sample were scored in
each experiment. Statistical significance was assessed using
unpaired non-parametricMan–Whitney compared ranks t-
test.
aniPOND
Samples for aniPOND were prepared as described (50).
Briefly, U-2 OS cells were depleted for Pds5A and Pds5B
using siRNA, or treated with negative siRNA as control.
Five 90% confluent 15 cm plates of siRNA-depleted cells
were required for each condition; two conditions for each
depletion (± thymidine chase). Five additional plates of the
siCrtl-depleted cells were prepared for the no-click control.
Cells were labeled with 10 M EdU for 20 min. For the
thymidine chase experiments, cells were first washed with
1× PBS and then treated with fresh media containing 10
M Thymidine for 1 h. After labeling and treatment, cells
were washed with 1× PBS and nuclei were harvested using 8
ml of nuclei extraction buffer (New England Biolabs). Cells
were scraped and the five plates used for each conditionwere
pooled in 50 ml tubes. Samples were then treated with 10 ml
of click reaction containing 25Mbiotin-azide, 10mM(+)-
sodium L-ascorbate and 2 mM CuSO4 and rotated at 4◦C
for 1 h. The no click control was treated with DMSO in-
stead of biotin-azide. Samples were then centrifuged to pel-
let the nuclei; supernatant was removed and replaced with 1
ml Buffer 1 (B1) containing 25 mMNaCl, 2 mMEDTA, 50
mM Tris–HCl pH 8.0, 1% IGEPAL and protease inhibitor
and rotated again at 4◦C for 30 min. This step was repeated
twice. Samples were centrifuged to pellet the nuclei; super-
natant was removed and replaced with 500 l of B1 and
sonicated six times for 10 s on and 10 s off at 20 ampli-
tude. Samples were centrifuged and supernatant was trans-
ferred to fresh tubes. To adjust the NaCl concentration to
physiological levels 500 l of Buffer 2 (B2) containing 150
mM NaCl, 2 mM EDTA, 50 mM Tris–HCl pH 8.0, 0.5%
IGEPAL and protease inhibitor was added to each sam-
ple. 20 l of each sample were removed and transferred to
fresh tubes contained 20 l of Laemli buffer and labeled
as ‘input’. The remaining sample (labeled as ‘capture’) was
incubated overnight (16–20 h) with 100 l of streptavidin-
coated beads for the streptavidin biotin capture step. Pro-
teins were eluted with 30 l of Laemli buffer and boiled at
95◦C for 15 min. Western blots were performed to monitor
the amount of Rad21, Pds5A and Pds5B at the replication
forks (– thymidine chase) and behind the replication forks
(+ thymidine chase).
iPOND-SILAC mass spectrometry
Samples for iPOND-SILAC MS were prepared as previ-
ously described (51,52). Briefly, VC8 cells complemented
with human BRCA2 were cultured in heavy isotope me-
dia and compared to VC8 cells lacking BRCA2 cultured in
light isotope media. After labeling with EdU and treating
with hydroxyurea, the cells were harvested and mixed prior
to performing the iPOND purifications. Mass spectrometry
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were required for protein identification. Quantitation is re-
ported as the log2 of the normalized heavy/light ratios.
Immunofluorescence microscopy
Twenty four hours following siRNA treatment, U-2 OS
cells were seeded onto microscope coverslips and incubated
at 37◦C for an additional 40 h. The cells were extracted
with 1× PBS containing 0.2% Triton X-100 and protease
inhibitors (Pierce) for 10 min on ice and fixed with 3.2%
paraformaldehyde in 1× PBS. The cells were then washed
extensively with IF Wash Buffer (1× PBS, 0.5% NP-40 and
0.02% NaN3), then blocked with IF Blocking Buffer (IF
Wash Buffer plus 10% FBS) for at least 30 min. Cells were
incubated with primary antibodies diluted in IF Blocking
Buffer overnight at 4◦C. Cells were stained with secondary
antibodies and mounted using Prolong Gold mounting
medium (Invitrogen). Epifluorescence microscopy was per-
formed on an Olympus fluorescence microscope (BX-53)
using an UPlanS-Apo 60×/1.35 oil immersion lens. Images
were obtained using an ORCA-Flash4.0 LT digital cam-
era and cellSens Dimension software. Raw images were ex-
ported into Adobe Photoshop, and for any adjustments in
image contrast or brightness, the levels function was ap-
plied. Nuclear Rad21 mean intensity levels were measured
using the histogram function in Photoshop. The number of
53BP1 nuclear bodies in CENP-F negative (G1) cells was
quantified manually. At least 200 cells were analyzed for
each experiment.
RESULTS
Pds5 controls replication fork progression
We sought to investigate the contribution of the two iso-
forms of Pds5 in replication fork progression by genome-
wide single-molecule DNA replication assays. We knocked
down Pds5A and Pds5B by siRNA in two different human
cells lines commonly used to study perturbations in repli-
cation fork dynamics, the human retinal pigment epithelial
(RPE-1) and osteosarcoma U-2 OS cells. Replication fork
progression was monitored by pulse-labeling cells with the
first thymidine analog 5-Iodo-2′-deoxyuridine (IdU, red la-
bel) for 20min followed by treatmentwith the second thymi-
dine analog 5-chloro-2’-deoxyuridine (CIdU, green label)
for the same amount of time in the absence of genotoxic
stress (Figure 1A). Shortening of the first and second tract
for each fork was measured as a readout of a defect in fork
progression only on forks characterized by contiguous IdU-
CldU signals (and not on forks that have only one label) to
ensure that the shortening phenotype is indeed due to a de-
fect in fork progression and not to premature termination
events. Pds5B loss inRPE-1 cells caused amarked reduction
in the IdU andCldU tract (approximately 44%) length (Fig-
ure 1A–D). A similar reduction was observed upon Pds5A
depletion (Figure 1A–D). Moreover, the CldU/IdU ratio
was very close to 1 (Supplementary Figure S1A) indicat-
ing that the replication fork defects associated with Pds5A
or Pds5B loss equally perturbs both tracts. Similar results
were obtained with the U-2 OS cells (Figure 1E, F and Sup-
plementary Figure S1B). Co-depleting both variants in U-2
OS cells did not further increase tract shortening, suggest-
ing that the two proteins are acting in the same pathway
(Figure 1F). The same results were also confirmed using
Pds5A and Pds5B knockout immortalized mouse embry-
onic fibroblasts (Pds5A KO and Pds5B KO iMEFs) ruling
out the possibility that the phenotype observed with the
siRNA depleted cells might be associated to an off-target
effect of the selected siRNAs (Figure 1G, H and Supple-
mentary Figure S1C). Collectively, these results suggest that
both Pds5 isoforms play an important and previously unap-
preciated role in replication fork progression in unperturbed
cells.
Pds5 role in replication fork progression is uncoupled from
BRCA2
Pds5B was previously reported to interact with BRCA2
(32,34). First, we confirmed the Pds5B–BRCA2 interaction
usingHEK293T cells expressing amyc-BirA-tagged version
of Pds5B (Supplementary Figure S2A). We also confirmed
the same results using a GFP-tagged version of the protein
and showed that the interaction persists under conditions
of replication stress (Supplementary Figure S2B). Next, we
utilized a recently improved iPOND (isolation of Proteins
on Nascent DNA) protocol coupled to SILAC mass spec-
trometry (51,52) to study whether Pds5 loads on nascent
DNA and whether its loading its affected by BRCA2 sta-
tus. Using iPOND, we compared the association of Pds5 as
well as other sister chromatid cohesion factors with nascent
DNA in the BRCA2 mutant VC8 hamster cell line and
its complemented derivative expressing wild-type BRCA2
(36,54,55). We found that most of sister chromatid cohe-
sion components, including the cohesin-ring components
Rad21, SA1 and SA2, the cohesion loading complex sub-
unit MAU2, and the cohesin unloading factors Pds5A,
Pds5B, and Wapl are present on nascent DNA (Table 1).
Robustness of the method was evident from the identi-
fication of all six components of the replicative helicase
MCM2-7, as well as of PCNA and RPA. The main com-
ponents of the histone core complex (H2A, H2B, H3 and
H4) were also present consistent with their rapid assembly
onto newly synthesized DNA. Moreover, the log2 ratios of
amount of proteins detected in BRCA2-proficient versus de-
ficient cells showed that the association of all the cohesin
components as well as of the core replication factors was
not significantly affected by BRCA2 status (Table 1, column
‘No treatment±BRCA2’). These results suggest that the re-
ported BRCA2–Pds5B interaction does not affect the abil-
ity of Pds5 as well as other sister chromatid cohesion factors
to interact with newly synthesized DNA.
Aside from its well-established role in HR, BRCA2 has
recently emerged as an important factor during replica-
tion stress response (35,36,40,44,56–59). Thereby, we also
sought to investigate whether the interaction of sister chro-
matid cohesion factors with replication forks might be
specifically affected by BRCA2 status under conditions of
replication stress. To this purpose, we repeated the iPOND
experiments treating cells with 4 mM HU for 2 hours and
compared the log2 ratios of amount of proteins detected in
BRCA2-proficient versus deficient cells in the presence of
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Figure 1. Pds5 controls replication fork progression. (A) Single-molecule DNA fiber-labeling scheme. (B) Expression of Pds5A and Pds5B after siRNA
knockdown in RPE-1 cells. (C) Representative DNA fiber images of RPE-1 cells transfected with control siRNA (Ctrl), Pds5A, or Pds5B siRNA. Scale bar
10 m. (D) Size distribution of IdU and CIdU tract length in Pds5A and Pds5B depleted RPE-1 cells. Cells were transfected with control siRNA (Ctrl),
Pds5A, or Pds5B siRNA before IdU and CldU labeling, as indicated. Bars represent the mean. Out of two repeats; n ≥ 300 tracts scored for each data set.
Statistics: Mann–Whitney; ****P< 0.0001. (E) Expression of Pds5A and Pds5B after siRNA knockdown in U-2 OS cells. (F) Size distribution of IdU and
CIdU tract length in Pds5A and Pds5B depleted U-2 OS cells. Cells were transfected with control siRNA (Ctrl), Pds5A, Pds5B and Pds5A/Pds5B siRNA
before IdU and CldU labeling, as indicated. Bars represent the mean. Out of two repeats; n≥ 300 tracts scored for each data set. Statistics: Mann–Whitney;
****P< 0.0001. (G) Expression of Pds5A and Pds5B in the Pds5B and Pds5A knockoutMEFs. (H) Size distribution of IdU and CIdU tract length inWT,
Pds5B and Pds5A knockout MEF cells. Bars represent the mean. Out of two repeats; n ≥ 300 tracts scored for each data set. Statistics: Mann–Whitney;
****P < 0.0001.
case, we used the Rad51 protein as a positive control for
a factor that should dissociate from replication forks upon
BRCA2 loss (56,60,61). Indeed, we found that the Rad51
association was significantly decreased in the BRCA2 mu-
tant cells. However, we did not find any significant change
in the association of the sister chromatid cohesion factors
and the core replisome components with replication forks
suggesting that the function of BRCA2 in replication stress
response is uncoupled from Pds5B (Table 1, columns ‘Hy-
droxyurea ± BRCA2’).
In agreement with the iPOND results, we found that
BRCA2 loss did not lead to the same fork progression de-
fect observed upon Pds5A and Pds5B loss in unperturbed
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Table 1. Table summarizing the relative abundance of selected proteins obtained by iPOND-mass spectrometry. Values are log2 of the ratio observed with
and without BRCA2. Positive values indicate proteins that are more abundant in cells containing BRCA2. Peptide numbers are the number of peptides
with quantifiable Heavy/Light ratios in that experiment. Values highlighted in bold are significant using the ‘Significance A’ test in Perseus after applying
Benjamini Hochberg FDR correction. See Cox and Mann 2008 Nature Biotechnology for details of the statistical test (53)
No treatment ± BRCA2
Hydroxurea Replicate 1 ±
BRCA2
Hydroxurea Replicate 2 ±
BRCA2























G3H154 Histone H2A 0.15 5.08 7 0.40 9.85 10 –0.13 32.13 8
G3HDT6 Histone H2A type 1 –0.19 15.97 148 –0.18 17.40 73 –0.33 21.56 68
G3I968 Histone H2A 0.21 3.99 8 0.35 4.89 7 0.03 8.40 7
G3HDT7 Histone H2B NO 11.39 29 0.06 24.93 57 –0.32 21.69 72
G3H2T7 Histone H3 –0.07 9.51 122 0.00 18.26 50 –0.22 30.15 52
G3HHM2 Histone H3.1t –0.06 24.16 98 0.17 N/A 1 –0.17 N/A 1
G3HDT9 Histone H4 –0.04 29.12 6 –0.62 118.58 4 –0.45 15.90 5
G3HPV7 Histone H4 –0.07 21.56 264 0.03 22.53 179 –0.13 24.47 196
Replicative Helicase
G3H7V9 DNA helicase MCM2 –0.01 14.26 67 0.07 23.19 49 0.23 26.90 38
G3I1H0 DNA helicase MCM3 0.04 13.26 116 0.05 16.32 56 0.27 15.65 54
G3I2I1 DNA helicase MCM4 –0.02 23.90 60 0.07 34.40 53 0.22 27.95 45
A0A061IB94 DNA helicase MCM5 0.00 30.46 81 0.06 18.41 67 0.20 17.03 47
G3GZQ9 DNA helicase MCM6 0.00 16.55 70 0.04 13.92 31 0.28 20.82 28
A0A061I6D0 DNA helicase MCM7 –0.05 21.72 87 0.09 32.17 62 0.26 14.10 54
PCNA
P57761 Proliferating cell nuclear
antigen; PCNA
0.16 18.19 169 0.25 8.91 39 0.72 25.95 45
RAD51
P70099 DNA repair protein RAD51 NO N/A N/A 2.26 40.85 2 3.17 108.35 7
Replication Protein A
G3HJH9 Replication protein A 14 kDa
subunit; RPA3
NO N/A N/A 0.49 10.30 8 0.56 7.00 33
G3H201 Replication protein A 32 kDa
subunit; RPA2
0.21 11.05 13 0.54 9.30 45 0.68 19.40 37
G3IP86 Replication protein A 70 kDa
subunit; RPA1
0.23 20.21 32 0.55 13.64 23 0.78 28.57 29
Cohesin Subunits
G3IBF6 Sister chromatid cohesion
protein PDS5-like A
0.13 20.60 35 –0.19 16.90 16 0.02 22.34 14
G3HM82 Sister chromatid cohesion
protein PDS5-like B
0.07 25.80 54 0.10 15.83 47 –0.09 19.24 45
G3H0A3 Double-strand-break repair
protein rad21-like
0.07 16.43 14 0.14 45.91 14 0.05 16.23 13
A0A061I2V2 Cohesin subunit SA-1 isoform 1 –0.02 13.97 11 0.01 12.70 11 –0.15 17.13 12
G3HY68 Cohesin subunit SA-2 0.07 33.00 33 0.23 10.32 21 0.09 19.47 16
G3H467 Cohesin loading complex
subunit SCC4-like
0.02 N/A 1 0.05 12.01 2 NO N/A N/A
A0A061IQY6 Putative MAU2 chromatid
cohesin protein
0.08 17.13 30 0.12 16.23 11 –0.15 20.45 12
N/A WAPL cohesin release factor 0.03 6.74 8 0.22 19.07 5 –0.13 20.81 7
*NO = not observed.
tion is not relevant for the fork progression function of
Pds5B (Figure 2A and Supplementary Figure S1D). More-
over, co-depletion of Pds5B and BRCA2 did not further ex-
acerbate the fork progression defect observed in Pds5B de-
pleted cells, confirming that BRCA2 does not play a role
during normal replication, as previously reported (36). To
study fork progression under conditions of genotoxic stress,
we pulsed-labeled replication events with the two thymi-
dine analogs, followed by treatment with 4 mM hydrox-
yurea (HU) for 2 h (Figure 2B). Previous studies suggested
that BRCA2 is required to protect stalled replication forks
from nucleolytic degradation following genotoxic stress in-
duction (36,58,59). In agreement with these observations,
we found that BRCA2 loss led to a significant shortening of
the CldU tract inHU-treated cells, whereas the length of the
IdU tracts was not significantly affected (Figure 2B). These
results are consistent with notion that BRCA2 loss leads to
an extensive nucleolytic degradation of the newly synthe-
sized DNA, with a consequent loss of the signal originat-
ing from the thymidine analog that was incorporated im-
mediately before HU treatment. Pds5B loss behaved differ-
ently from BRCA2 because it promoted a significant short-
ening of both IdU (red) and CldU (green) tracts in the
presence and absence of HU (Figures 2A and B). Specifi-
cally, treatment withHUdid not further exacerbate the fork
progression defect observed in untreated Pds5B depleted
cells. Moreover, combined depletion of Pds5B and BRCA2
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Figure 2. The role of Pds5 in replication fork progression is uncoupled from BRCA2 and compromises fork restart upon prolonged HU treatment. (A, B)
Size distribution of IdU and CldU tract length in Pds5B, BRCA2 and Pds5B/BRCA2 siRNA depleted U-2 OS Cells. Untreated cells (A) and HU treated
cells (B). Bars represent the mean. Out of two repeats; n ≥ 300 tracts scored for each data set. Statistics: Mann–Whitney; ****P < 0.0001. (C) Single-
molecule DNA fiber labeling scheme used for the fork restart experiments and representative images of stalled and restarting forks. Scale bar 5 m. (D)
Quantification of stalled/terminated forks and restarting forks after HU treatment in control, Pds5A, Pds5B, Wapl and Rad21, BRCA2 siRNA depleted
U-2 OS cells. Out of three repeats, the percentage is established on at least 1000 tracts scored for each data set. Data are represented as mean ± SD.
Statistics: two-way ANOVA. P values, restarted forks: siControl versus siPds5A **P = 0.0088; siControl versus siPds5B ***P = 0.0010; siControl versus
siWapl *P = 0.0127; siControl versus siRad21 ns, P = 0.3881; siControl versus siBRCA2 ns, P = 0.9998. Stalled forks: siControl versus siPds5A ***P
= 0.0002; siControl versus siPds5B ****P < 0.0001; siControl versus siWapl ***P = 0.0002; siControl versus siRad21 ns, P = 0.2757; siControl versus
siBRCA2 ns, P = 0.9878. ns, not significant. (E) Quantification of stalled/terminated forks and restarting forks in WT, Pds5A, and Pds5B knockout MEF
cells. Out of three repeats, the percentage is established on at least 1000 tracts scored for each data set. Data are represented as mean ± SD. Statistics:
two-way ANOVA. P values, restarted forks: siControl versus siPds5A *P= 0.0474; siControl versus siPds5B ns, P= 0.0617. Stalled forks: siControl versus
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tracts. However, a proper analysis of the double-depletion
experiments is complicated by the fact that the tracts were
already very short upon Pds5B loss. Taken together these re-
sults suggest that Pds5B is acting independently of BRCA2
at the replication forks and that, unlike BRCA2, is impor-
tant for replication fork progression both in perturbed and
unperturbed conditions.
Pds5 is required for fork restart after prolonged HU treat-
ment
Given that Pds5 loss affects replication forks progression,
we sought to investigate whether it also affects the ability of
replication forks to restart after HU removal. To this pur-
pose, we pulse-labeled Pds5A- and Pds5B-depleted U-2 OS
cells with IdU for 20 minutes, followed by treatment with
HU for five hours and labeling with the second thymidine
analog CldU for 20 min after drug removal (Figure 2C).
Using this labeling scheme, we can calculate the percent-
age of forks that have restarted by quantifying tracts that
are red followed by green (restarting forks) and those that
are only red (representing replication forks that were unable
to restart following genotoxic stress induction) (Figure 2C).
We found that, unlike BRCA2, loss of Pds5A or Pds5B lead
to a significant increase in the percentage of stalled repli-
cation forks after prolonged exposure to HU (Figure 2D).
Concomitantly, we also observed a parallel decrease in the
percentage of restarting forks. The same results were ob-
tained using the Pds5A and Pds5B KO MEF cells (Figure
2E).
Unlike Pds5, BRCA2 depletion did not significantly af-
fect the ability of the stalled forks to restart upon drug
removal (Figure 2D), in agreement with recent findings
(36,40,58). Of note, other studies pointed to a potential role
for BRCA2 in fork restart suggesting that its effect might
vary as a function of the cell type or the particular condi-
tions used to stall replication forks (62,63). The different
fork restart phenotypes observed upon Pds5 and BRCA2
depletion in our cell lines further confirm that the Pds5 and
BRCA2 play distinct functions during replication stress.
Next, we investigated whether the fork restart defect asso-
ciated with Pds5 loss was shared by other cohesion factors.
Depletion of Rad21, one of the core components of the co-
hesin ring, did not significantly affect the ability of replica-
tion forks to restart upon drug removal (Figure 2D). On the
other hand, depletion of the other cohesin unloading fac-
tor, Wapl, caused a significant increase in the percentage of
stalled replication forks, mimicking the effect of Pds5A or
Pds5B depletion (Figure 2D). These results suggest cohesin
removal function of Pds5A/Pds5B and Wapl is important
for normal replication fork progression and restart.
MRE11 activity is the cause of the fork progression defect
associated with Pds5 loss
The MRE11 nuclease forms a trimeric complex compris-
ing MRE11, Rad50 and Nbs1 (MRN) and it is best known
for its role in DSB resection (64,65). Recent studies suggest
that MRE11-dependent resection is also crucial for stalled
replication fork processing through a tightly regulated pro-
cess thatmust ensure a limited degradation of nascentDNA
strands required for efficient fork processing and restart
(66–68). However, MRE11-dependent resection can also
lead to extensive and uncontrolled degradation of stalled
replication forks in the absence of selected Fanconi Ane-
mia (FA) and Homologous Recombination (HR) factors,
including the Fanconi Anemia Complementation Group
D2 (FANCD2) factor, BRCA1 and BRCA2 (36,58,59). To
investigate whether the fork slowing phenotype associated
with Pds5 loss is linked to nucleolytic degradation, we in-
hibited MRE11 activity with the Mirin inhibitor before
pulse-labeling cells with the thymidine analogs (Figure 3A).
We found that MRE11 inhibition rescued the fork slow-
ing phenotype of Pds5A or Pds5B-depleted U-2 OS (Figure
3A) and RPE-1 (Supplementary Figure S3A) cells, suggest-
ing that Pds5A and Pds5B play an important role in reg-
ulating MRE11 activity. MRE11 knockdown in Pds5A or
Pds5B depleted U-2 OS, or in Pds5B knockout MEFs, led
to very similar results ruling out any possible off-target ef-
fect of theMRE11 inhibitor (Figure 3B and Supplementary
Figure S3B). Furthermore, the same results were obtained
by knocking down the other two subunits of the MRN
complex, Nbs1 and Rad50 (Supplementary Figure S3C–F).
These results suggest that the MRN complex is responsible
for fork slowing phenotype observed in Pds5 depleted cells.
MRE11-dependent fork slowing could arise as a con-
sequence of the MRE11-dependent degradation of repli-
cation forks, as already discussed, or an inhibitory ef-
fect of MRE11 on fork movement independent of fork
degradation. Recent studies suggest that the regressed
arms of reversed replication forks are the entry point for
MRE11 degradation in the absence of central HR factors
(40,44,56,57). Thus, we sought to investigate whether de-
pletion of factors required fork replication fork reversal ab-
rogates MRE11-dependent fork slowing. Indeed, we found
that loss of the central recombinase Rad51 (69) or the
Smarcal1 translocase (44,56,70), which are both required
for replication fork reversal, rescues theMRE11-dependent
fork slowing phenotype associated with loss of Pds5A or
Pds5B (Figure 3C and Supplementary Figure S3G and H).
Collectively, these results suggest that the MRE11 nucle-
ase might target reversed replication forks that accumulate
upon Pds5 loss.
Loss of Rad21 rescues fork progression upon Pds5 depletion
Next, we sought to investigate whether the fork progression
defect observed upon Pds5A or Pds5B depletion could be
recapitulated by knocking down other sister chromatid co-
hesion factors. We found that depletion of Wapl, which to-
gether with Pds5 is needed to release cohesin from DNA,
lead to the same shortening of the IdU tracts observed upon
Pds5A or Pds5B loss (Figure 4A and Supplementary Figure
S4A).Moreover, co-depletion of Pds5A or Pds5B andWapl
did not lead to a further decrease in the size of the IdU tracts
pointing to an epistatic role for Pds5 andWapl in replication
fork protection. In contrast to Pds5 and Wapl, depletion
of core cohesin-ring component Rad21 did not significantly
affect fork progression (Figure 4B and Supplementary Fig-
ure S4B–D). Surprisingly, co-depletion of Pds5A or Pds5B
and Rad21 completely rescued the fork slowing phenotype
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Figure 3. MRE11 degrades reversed replication forks in the absence of Pds5. (A) Single-molecule DNAfiber labeling scheme (top). Size distribution of IdU
tract length in Pds5A and Pds5B siRNAdepletedU-2 OS cells treated with 50MMirin. Bars represent the mean. Out of two repeats; n≥ 300 tracts scored
for each data set. Statistics: Mann–Whitney; ****P < 0.0001. (B) Size distribution of IdU tract length in Pds5A, Pds5B, MRE11, Pds5A/MRE11 and
Pds5B/MRE11 siRNA depleted U-2 OS cells. Bars represent the mean. Out of two repeats; n ≥ 300 tracts scored for each data set. Statistics: Mann–
Whitney; ****P < 0.0001. (C) Size distribution of IdU length in Rad51 or Smarcal1 siRNA depleted U-2 OS cells in the presence and absence of Pds5A
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Figure 4. Cohesin depletion rescues the fork progression defects associ-
ated with the loss of Pds5 or Wapl. (A) Single-molecule DNA fiber label-
ing scheme (top). Size distribution of IdU tract length in Pds5A, Pds5B,
Wapl, Pds5A/Wapl and Pds5B/Wapl siRNA depleted U-2 OS cells (bot-
tom). Bars represent the mean. Out of two repeats; n ≥ 300 tracts scored
for each data set. Statistics: Mann–Whitney; ****P < 0.0001. (B) Size
distribution of IdU tract length in Pds5A, Pds5B, Wapl, Pds5A/Rad21,
Pds5B/Rad21 and Wapl/Rad21 siRNA depleted U-2 OS cells. Bars rep-
resent the median. Out of two repeats; n ≥ 300 tracts scored for each data
set. Statistics: Mann–Whitney; ****P < 0.0001. (C) AniPOND of Pds5A
siRNAdepletedU-2OS cells. (D) AniPONDof Pds5B siRNAdepletedU-
2 OS cells. No-Click control: no biotin was added. Edu: cells treated with
EdU for 20 minutes and then harvested. Chase: cells treated with Edu for
20 min, washed and treated with a thymidine chase for 1 h and then har-
vested. Proteins present at the replication forks were recovered using strep-
tavidin beads. Proteins enriched at the fork were detected by western blot.
co-depletion of Wapl and Rad21 rescued the fork slow-
ing phenotype of Wapl depleted cells (Figure 4B). These
results suggest that the fork slowing phenotype observed
upon Pds5 or Wapl depletion is linked to an aberrant load-
ing of cohesin on replication forks and can be rescued by
cohesin removal.
Loss of Pds5 decreases cohesin levels behind replication forks
On the basis of our observation that Rad21 depletion res-
cues the fork progression defect associated with Pds5 loss,
we sought to investigate whether loss of Pds5A or Pds5B
affects cohesin loading on replication forks. To this end, we
studied the recruitment of Rad21 to the replication forks
using a slightly modified version of the iPOND protocol,
called aniPOND (50). Moreover, we can test whether the
same proteins are recruited at some distance behind forks
using a thymidine chase. Histone 3 (H3) was used as a load-
ing control. PCNA was used as a positive control for pro-
teins present at the fork and as a negative control in the
chase, as PCNA travels with replication forks and would
not be captured by the EdU label behind the fork.We found
that Pds5 andRad21 were associated with the newly synthe-
sized tracts (EdU) (Figure 4C and D), in agreement with
the iPOND-mass spectrometry results (Table 1). Moreover,
the thymidine chase experiments showed that both proteins
were also present behind the fork, in agreement with the no-
tion that cohesin relocates behind replication forks to en-
sure sister chromatid cohesion. On the other hand, loss of
Pds5A and Pds5B decreased Rad21 levels both at forks and
behind the forks (Figure 4C andD). These data suggest that
Pds5 depletion leads to a significant reduction of the co-
hesin levels on replication forks and behind them. Next, we
sought to investigate whether the overall levels of chromatin
bound Rad21 are affected by loss of Pds5 by chromatin
fractionation and immunofluorescence experiments (Fig-
ure 5). We found the levels of chromatin bound Rad21 re-
main unchanged upon Pds5 depletion. These experiments,
combined with the iPOND experiments described above,
suggest the cohesin rings bound ahead of replication forks
might not be efficiently relocated behind the forks in the ab-
sence of Pds5 leading to a reduction of cohesin levels behind
forks without a significant change in the overall cohesin lev-
els bound to DNA.
Pds5 or Wapl loss leads to increased DSB accumulation,
which is rescued by Rad21 depletion
To investigate the functional consequences of the fork pro-
gression defect observed upon Pds5 or Wapl depletion, we
monitored whether loss of these essential cohesin removal
factors leads to increased double-strand breaks (DSBs) ac-
cumulation and chromosomal aberrations. Using neutral
comet assays, we found that depletion of Pds5A, Pds5B or
Wapl lead to a significant increase in DSBs in unperturbed
U-2 OS cells (Figure 6A). The same results were recapitu-
lated using the Pds5A and Pds5B knockout MEFs and was
further exacerbated by HU treatment (Supplementary Fig-
ure S4E). As an additional readout of DSBs accumulation,
we also found that loss of Pds5Aor Pds5B leads to amarked
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Figure 5. Loss of Pds5 does not alter cohesin loading on chromatin. (A) Levels of Rad21 bound to chromatin after depletion of Pds5A (top) or Pds5B
(bottom). Chromatin Fractionation of Pds5 depleted U-2 OS cells. Fractions separated included whole cell, chromatin bound and soluble cytoplasmic
proteins. Samples were probed with Pds5A, Pds5B, Rad21, Tubulin and H3 antibodies. (B) Relative intensity of Rad21 bound to chromatin after im-
munofluorescence staining of Pds5A or Pds5B depleted cells. Cells were pre-extracted to remove soluble proteins, leaving chromatin bound proteins intact.
Quantification of the Rad21 relative intensity signal. At least 100 cells were scored for each data set. n= 2. Data are represented as mean± SEM. Statistics:
Mann–Whitney; ****P < 0.0001.
it did not significantly affect the cellular levels of p-Chk1 or
p-RPA (Supplementary Figure S5). In agreement with the
results of the DNA fiber experiments, we also found that
inhibition of MRE11 activity rescues the DSBs detected in
the absence of Pds5A, Pds5B, or Wapl suggesting that the
DSBs accumulation caused by the loss the releasin factors is
a consequence of the MRE11-dependent processing of the
nascentDNA strands (Figure 6A).Moreover, we found that
loss of Rad21 also rescued the observed increase in DSBs
supporting the notion that these DSBs are associated to the
replication defects linked to Pds5 orWapl depletion (Figure
6B).
Chromosome spread analysis showed that Pds5A and
Pds5B depletion also led to increased chromosomal insta-
bility in unperturbed U-2 OS cells (Figure 6C). This ef-
fect was again partially rescued by Rad21 depletion. How-
ever, Rad21 depletion alone also led to a significant increase
in chromosomal breaks and alterations in cell morphology
(Figure 6C and Supplementary Figure S4F), in agreement
with the notion that loss of cohesion leads to improper
chromosomal segregation and increased genomic instabil-
ity (11,71). Collectively, these results suggest that the fork
slowing phenotype associated with the Pds5 loss leads to
consequent accumulation of DSBs and chromosomal aber-
rations. This phenotype can be partially rescued by Rad21
depletion suggesting that it may be associated with aberrant
accumulation of cohesin rings on replication forks, as also
suggested by our aniPOND experiments.
DISCUSSION
Replication fork progression is constantly challenged by
DNA lesions and intrinsic replication fork obstacles. Co-
hesin is loaded on the DNA in late G1 phase and is present
on the DNA throughout S phase while DNA is replicated
(17,72). Here, we found that the Pds5 protein plays a crucial
role in replication fork progression by regulating a proper
re-distribution of the cohesin rings on the ongoing repli-
cation forks. In its absence, replication forks are targeted
by the MRE11 nuclease and fail to promptly restart when
challenged with HU. This function of Pds5 is uncoupled
to its previously reported interaction with BRCA2 and is
shared by the other component of the cohesin releasin com-
plex, Wapl. On the basis of these results, we propose that
perturbing cohesin dynamics on replication forks poses an
important and previously unappreciated formof replication
challenge that must be properly controlled to ensure repli-
cation fork progression.
Pds5B has been shown to interact with several HR fac-
tors, including Rad51, Palb2 and BRCA2 upon DNA dam-
age induction (32–34). Recent studies showed that BRCA2
and Rad51 have a HR-independent role in replication fork
stability upon genotoxic stress induction (40,44,56,57). We
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Figure 6. Loss of Pds5 leads to increased DSBs and chromosomal aberrations. (A) Neutral Comet assay monitoring DSB formation in in Pds5A, Pds5B or
Wapl siRNA depleted U-2 OS cells treated with 50 MMirin or left untreated. Representative images of comets of Pds5A, Pds5B, Rad21 or Wapl siRNA
depleted cells with or without 50MMirin (top). Out of three repeats; n≥ 100 comets scored for each data set. Data are represented asmean± SEM. Statis-
tics:Mann–Whitney; ****P< 0.0001 (bottom). (B)Neutral Comet assaymonitoringDSB formation in Pds5A, Pds5B,Wapl, Pds5A/Rad21, Pds5B/Rad21
and Wapl/Rad21 siRNA depleted U-2 OS cells. Representative images of comets of Pds5A, Pds5B, Rad21, Wapl, Pds5A/Rad21, Pds5B/Rad21 and
Wapl/Rad21 siRNA depleted cells (top). Out of three repeats; n ≥ 100 comets scored for each data set. Data are represented as mean ± SEM Statis-
tics: Mann–Whitney; ****P < 0.0001 (bottom). (C) Accumulation of DSB as measured by chromosome spread. Representative images of metaphases
of Pds5A, Pds5B, Rad21, Pds5A/Rad21 and Pds5B/Rad21 siRNA depleted cells (left). Red arrows point to DSBs. Bar graph, distribution of number
of chromosomal abnormalities per metaphase. At least 50 metaphases were counted from three independent experiments. Mean shown, n = 3. Statistics:
unpaired t-test; ****P < 0.0001. (D) Proposed model. Cohesin is recruited to origins in early S-Phase. Pds5/Wapl unload cohesin ahead of the fork to
allow fork passage. Cohesin is promptly re-assembled behind the replication fork to achieve sister chromatid cohesion. Whether the two sister chromatids
are embraced by two interacting cohesin complexes, as shown in the figure, or by a single-complex is still controversial in the field (84–87). In the absence
of Pds5 or Wapl, there is a reduction in cohesin loading behind the forks suggesting that there might be a consequent accumulation of cohesin rings ahead
of replication forks. This aberrant re-distribution of the cohesin rings might cause MRE11-dependent degradation of the newly synthesized DNA strands,
leading tract shortening, DSB accumulation and chromosomal instability. Tract shortening could also be due to an inhibitory effect of MRE11 on fork
movement independent of fork degradation as discussed in the main text.
fork progression in unperturbed conditions suggesting that
the role of Pds5 during DNA replication is distinct from the
previously reported function of BRCA2 andRad51 in repli-
cation fork stability. We also found that Pds5B depletion in-
creases fork stalling under conditions of replication stress.
This phenotype is again different from that of BRCA2-
deficient cells because loss of BRCA2 does not significantly
affect the ability of replication forks to restart upon drug
removal (36,40,58). Of note, loss of the other Pds5 variant,
Pds5A, which does not interact with BRCA2, mimics the
phenotype observed upon Pds5B depletion further support-
ing the idea that the function of the two Pds5 variants dur-
ing replication is uncoupled from BRCA2. Along the same
lines, our iPOND data show that the loading of Pds5, as
well as the core component of the cohesin complex, is not
affected by BRCA2 loss both in the presence and absence of
replication stress. On the basis of these results, we propose
the role of Pds5 during replication is independent from its
interaction with HR factors, and is may be connected to its
function in cohesin removal.
On the other hand, the interaction of Pds5BwithHR fac-
tors might become important under conditions that lead to
replication fork breakage and DSB accumulation. In this
context, Pds5B seems to be important for the proper local-
ization of BRCA2 and Rad51 at damaged sites during HR-
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Pds5B was shown to interact with BRCA2 in response to
agents that stall replication forks under conditions of pro-
longed drug treatment, which cause significant DSB accu-
mulation (32). This conclusion is also supported by our data
showing that the interaction between Pds5B–BRCA2 per-
sists upon prolonged exposure to HU treatment pointing
to a potential role of this complex following replication fork
breakage.
We found that chemical inhibition of MRE11 activity
using Mirin or reduction in protein levels by siRNA or
shRNA rescued the pronounced shortening phenotype as-
sociated with Pds5A or Pds5B loss both in human and
mouse cells. Furthermore, we were able to rescue this re-
section phenotype by depleting the two other components
of the MRN complex, Nbs1 and Rad50. Specifically, Nbs1
depletion prevents MRE11 and Rad50 from being trans-
ported into the nucleus (73), whereas loss of Rad50 desta-
bilizes the whole MRN complex (74). On the basis of these
results, we propose that the MRE11 nuclease is responsi-
ble for the pronounced slowing phenotype associated with
Pds5A or Pds5B loss. MRE11 travels with the replication
machinery and the limited MRE11-dependent resection of
nascent strands is required for efficient fork processing and
restart (66–68). However, MRE11 activity can also lead to
an extensive and uncontrolled degradation of replication in-
termediates in specific genetic backgrounds (75). The rea-
son for the MRE11-dependent fork slowing phenotype as-
sociated with Pds5 loss could be either due to the MRE11-
dependent degradation of the replication forks or an in-
hibitory effect of MRE11 on fork movement independent
of fork degradation. In this regard, recent studies suggest
that the regressed arms of reversed replication forks are the
entry point forMRE11 in the absence of central HR factors
(40,44,56,57). Indeed, we found that suppression of replica-
tion fork reversal by depletion of the central recombinase
Rad51 (69) or the Smarcal1 translocase (44,56,70) rescues
the MRE11-dependent fork slowing phenotype associated
with loss of Pds5A or Pds5B. These data suggest that re-
versed forks might be the structures targeted by MRE11 in
the absence of Pds5 and that the DSBs detected upon Pds5
loss might arise form nucleolytic cleavage of reversed forks.
Interestingly, reversed forks were previously shown to be
degraded by MRE11 only upon HU treatment under spe-
cific genetic backgrounds, such as in BRCA1- or BRCA2-
deficient cells (40,44,56,57). In particular, these studies sug-
gested that BRCA proteins load on the reversed forks to
protect the regressed arms from degradation only under
conditions of replication stress. We posit that the reversed
forks that form upon Pds5 loss in the absence of HU might
not trigger BRCA recruitment, thus remaining unprotected
and exposed to nucleolytic degradation. However, accurate
electron microscopy studies would be needed to fully vali-
date this conclusion.
Structural studies previously reported that the inner di-
ameter of the cohesin ring is approximately 50 nm (5,76).
Advances in single molecule technology have helped un-
cover the flexibility of the cohesin ring loaded on DNA. In
particular, recent work suggests that the cohesin ring may
be loaded on the DNA in a collapsed form making the di-
ameter of the ring much smaller than initially predicted (ap-
proximately 10–19 nm) (77). Moreover, single-molecule ex-
periments have shown that cohesin is loaded topologically
onto the DNA where it can translocate along the strand
if pushed by DNA motor proteins (77,78). The replisome
is a multi-protein macromolecular machinery, much larger
than the inner diameter of the cohesin ring pore (79,80).
Therefore, cohesin molecules present ahead of replication
forks need to be promptly removed by the releasin complex
to allow passage of the replication forks unless forks are
somehow capable of traversing through the rings (81). Co-
hesin will then need to be reloaded behind the fork to hold
the newly synthesized strands together and ensure proper
sister chromatid cohesion. In this regard, a recent study
showed that cohesin ubiquitination facilitates cohesin dy-
namics on replication forks (82). The exact mechanism by
which this process occurs is still much debated in the field.
Our data show that disruption of the releasin complex, by
Pds5 or Wapl depletion, perturbs replication fork progres-
sion, leading to replication tract shortening. This pheno-
type is rescued by depletion of the core cohesin-ring com-
ponent Rad21. Together, these findings support a model
whereby loss of either component of the releasin complex
compromises the ability of the cohesin rings to be removed
fromDNAand the aberrant re-distribution of cohesin rings
on replication forks lead to the observed replication de-
fects. Consistently, our aniPOND experiments show that
there is a decreased amount of cohesin loaded behind the
forks following Pds5A and Pds5B knockdown suggesting
that the absence of Pds5 orWapl perturbs cohesin dynamics
on replication forks. Unfortunately, the iPOND approach
is not designed to detect proteins ahead of replication forks
and future studies should aim to test this possibility by us-
ing alternative techniques. Moreover, our aniPOND data
do not rule out the alternative possibility that there is sim-
ply an overall reduction in cohesin levels bound to DNA
upon Pds5 and Wapl knockdown. To rule out this alterna-
tive possibility, we performed chromatin fractionation and
immunofluorescence experiments showing that overall lev-
els of Rad21 remain largely unchanged upon Pds5 deple-
tion. These experiments, coupled with our observation that
Pds5 loss decreases the Rad21 levels behind forks, support
a model where Pds5 loss compromises the proper relocation
of cohesin rings on replication forks.
As discussed above, MRE11 travels with the replica-
tion machinery (66–68). A possible interpretation for why
perturbing cohesin dynamics on replication forks leads to
MRE11-dependent degradation could be simply that the in-
efficient relocalization of cohesin rings slows down replica-
tion forks and gives more time for MRE11 to act on the
forks, leading to extensive nascent strand degradation (Fig-
ure 6D). Alternatively, aberrant loading of cohesin might
somehow affect the distribution or activity of the MRN
complex in the ongoing replication forks thereby leading to
uncontrolled nascent strand DNA resection. However, fu-
ture biochemical studies would need to be performed to de-
fine the mechanistic link between aberrant cohesin loading
and MRE11 activity.
In summary, our data suggest that altering cohesin ring
dynamics by Pds5 or Wapl loss perturbs normal replica-
tion fork progression and leads to uncontrolled MRE11-
dependent degradation of the nascent DNA strands. This
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nomic instability (Figure 6D). Our findings provide a new
rationale for the recently identified tumor suppressor func-
tion of Pds5B (83) and for the previously reported corre-
lation between Pds5B expression levels and breast cancer
patient survival following treatment with DNA-damaging
chemotherapy (32).
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